The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
REAGILA (Gedeon Richter Australia Pty Ltd)
Product name
REAGILA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
196 working days (255)
Active ingredients
cariprazine hydrochloride
Registration type
NCE/NBE
Indication
REAGILA (hard capsule) is indicated for the treatment of schizophrenia in adult patients.